Sus voluntary event report number: mw5090432.A voluntary event form was received from the fda at (b)(6) by postal service mail on 11/7/2019.Per the voluntary event report, customer reported to the fda that a 5cc syringe had a hairline crack along the barrel causing leakage and contamination of the radiopharmaceutical.The integrity and sterility of the product was compromised per the customer.On 12/3/2019 additional information was received.The (b)(6) pharmacist provided a picture of the cracked syringe.The pharmacist stated that tc-99m macro aggregated albumin was the drug that was filled in the syringe.The exact drug leakage amount was not known.The end user was (b)(6) hospital.Per the pharmacist, hospital personnel was contaminated with radioactive material, but there does not appear to have been a reported injury.(b)(6) pharmacist provided the customer (end user) investigative report.Summary of (b)(6) hospital investigative report: during a procedure on (b)(6) 2019, the doctor gave the syringe a stronger push and the force of the injection leaked through the syringe at a crack defect and dose was inadvertently sprayed onto doctor.The procedure was aborted after patient needs were met and the hospital radiation safety dept was notified.The doctor was asked to wash his face to remove any contamination.A personnel survey of the doctor by radiation safety staff showed no signs of skin contamination.So it is believed there was never any personnel skin contamination involved.As per the hospital report, radiation safety representatives surveyed and decontaminated the room.Multiple areas of the floor were surveyed and identified areas were cleaned until area surveys were reading background (0.02 mr/hr) and area wipe tests were all < 117 dpm.
|